Accent Therapeutics

About:

Accent Therapeutics is a biopharmaceutical company.

Website: https://www.accenttx.com/

Top Investors: AbbVie, Bristol-Myers Squibb, Google Ventures, Atlas Venture, EcoR1 Capital

Description:

Accent Therapeutics is a biopharmaceutical company developing oncology-focused, small molecule therapies in the emerging field of epitranscriptomics. This field of biology encompasses post-transcriptional chemical modifications of RNA that provide cells with a unique mechanism for regulating proteins critical for cellular growth and differentiation. By targeting cancer-linked RNA-modifying proteins (RMPs) with precision therapies, they aim to translate extraordinary science into life-changing therapies for patients.

Total Funding Amount:

$178M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Lexington, Massachusetts, United States

Founded Date:

2017-01-01

Contact Email:

contactus(AT)accenttx.com.

Founders:

Robert A. Copeland

Number of Employees:

11-50

Last Funding Date:

2024-01-23

IPO Status:

Private

Industries:

© 2025 bioDAO.ai